What an exciting day for Lighthouse —?a $370M funding round from KKR! Ever since our first investment in the company back in 2017, it has been an absolute pleasure to take this journey with Sean Fitzpatrick, Matthias Geeroms, Dave Collier, Mathias Verhoeven, and the rest of the team as they built what has become the leading commercial platform for the travel and hospitality industry. As Sean wrote in his announcement (find the link below), "This strategic partnership with KKR is a powerful signal of the potential we’re unlocking in the hospitality technology vertical." Many investors now recognize the massive potential in travel and hospitality, but very few platforms and teams have managed to achieve the scale to break out and become a category defining business like this one. Congratulations, all!
F-Prime Capital
风险投资与私募股权管理人
Cambridge，MA 21,250 位关注者
We create and invest in healthcare and technology companies that impact lives all over the world.
关于我们
Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds are larger and more global, but our teams are still small and local. We stay true to our entrepreneurial roots. In the US and Europe, we are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, our sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together we bring a world of insight, domain expertise and relationships to support our entrepreneurs. Without the pressure of fundraising from outside investors, we focus all of our time finding and helping great entrepreneurs build important companies.
- 网站
-
https://fprimecapital.com/
F-Prime Capital的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 11-50 人
- 总部
- Cambridge，MA
- 类型
- 私人持股
地点
-
主要
获取路线
One Main Street
US，MA，Cambridge，02142
F-Prime Capital员工
动态
-
We’re excited to share the latest installment of our “Pioneering Progress” series, now live, highlighting the inspiring journey behind Lenmeldy — a groundbreaking achievement from our portfolio company, Orchard Therapeutics. Approved by the FDA in March 2024, Lenmeldy offers a pioneering treatment for children with early-onset metachromatic leukodystrophy (MLD), a rare and fatal neurometabolic disorder. This milestone represents a transformative leap in patient care, giving children with MLD a new hope for longer, healthier lives. It’s a testament to the impact of our commitment to advancing science that not only changes lives but also reshapes the future of healthcare. To read “Pioneering Progress: The Lenmeldy Story,” please see our LinkedIn article below or visit the link in the comments. Alex Pasteur, Ph.D. │ Nihal Sinha, MB BChir │ Bobby Gaspar, M.D., Ph.D. #healthcare #innovation #raredisease?Orchard Therapeutics - U.S.
-
We're super excited for Notabene as they announce their $14.5M Series B today, led by DRW. Since we co-led the Series A alongside Jump Capital, Pelle Br?ndgaard, Alice Nawfal, Andres Junge, Ania Lipinska, and the rest of the team have gone from strength to strength. This round will help the team bring secure, transparent, and compliant crypto payments to more financial institutions, paving the way for stablecoins to revolutionize global finance. Check out Pelle's full blog via the comments section for more details on the round, what this means for Notabene, and the future of global finance. #CryptoCompliance #Fintech #DigitalPayments #CryptoRegulation
-
-
We're so excited to participate in Alluvial’s latest $4.3M funding round alongside Brevan Howard Digital and TrueBridge Capital Partners! The team will use this funding to accelerate institutional staking adoption and expand access to Liquid Collective. Together, we can bridge institutions into the onchain world, driving mainstream adoption through secure, trusted and interoperable staking solutions. Read the full announcement via the link in the comments ??
-
-
Venture Partner Steve Johnson hosted leading sales and marketing leaders from across the tech industry and our portfolio for dinner in Boston this week. We had a great time connecting and trading notes about emerging trends, tips, and tools for GTM! Gaurav and Ayla from F-Prime were there, along with Angela Singhal Whiteford, Betsy Miller Daitch, Brendan O'Donohoe, Eric Blatte, Jimi Guldstrand, Nolan Kelly, and Peter Caputa. Great to see you all, looking forward to catching up again soon!
-
-
Time is running out! #Science2Startup 2025, on Wednesday, May 14th, is a one-day symposium providing research applicants with a unique opportunity to receive guidance and mentorship from leaders in the biotech field.?? ? Submit your application via the link in comments by Friday, November 15th, to pitch your innovative startup ideas to leading #biotech and #pharma experts. ? Don’t miss your chance to apply!
-
-
For the first time since 2021, investment in robotics companies grew year-on-year. As you can see in the graph below — drawn from Sanjay Aggarwal and Betsy Mulé’s latest State of Robotics report, documenting robotics investment trends through the first half of 2024, vertical robotics, autonomous vehicles and humanoids are driving the rebound in robotics investment. The latter has been so big this year (see big rounds this year from 1X, Apptronik, and Figure, among others), we've broken it out into its own distinct category. Read on for more analysis from Betsy and Sanjay: https://lnkd.in/gU_SXVUa And check out the full report via the link in the comments.?
-
-
Join host firms F-Prime Capital, Atlas Venture, 5AM Ventures, Osage University Partners (OUP), and RA Capital Management, for the 2025 #Science2Startup symposium!? ? This year's event is set for Wednesday, May 14th, featuring top scientists presenting to an audience of leading #biotech and #pharma executives, VCs, and entrepreneurs.? ?? Have a groundbreaking idea for a biotech #startup??? Submit your application by Friday, November 15th using the link in the comments section.
-
-
This month on Fintech Prime Time, we’ve got a quick preview of our next subsector deep dive with Sarah Lamont, while Abdul Abdirahman takes a look at how falling interest rates have affected publicly traded fintech companies. Find the link in the comments.
-